The effect of pimecrolimus on innate immunity in subjects with atopic dermatitis: a double-blind, randomized, vehicle-controlled study

Authors


  • Funding sources: This work was supported by Novartis, East Hanover, NJ, U.S.A.

  • Conflicts of interest: This work was supported by Novartis, East Hanover, NJ, USA.

Tissa Hata.
E-mail: thata@ucsd.edu

Abstract

See also the Commentary by Danby and Cork

Ancillary